Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism

被引:19
|
作者
Barrington, S. F. [1 ]
Anderson, P. [2 ]
Kettle, A. G. [3 ]
Gadd, R. [4 ]
Thomson, W. H. [5 ]
Batchelor, S. [6 ]
Mountford, P. J. [4 ]
Harding, L. K. [5 ]
O'Doherty, M. J. [1 ]
机构
[1] St Thomas Hosp, PET Imaging Ctr, London SE1 7EH, England
[2] Queen Elizabeth Hosp, Dept Nucl Med, Birmingham B15 2TH, W Midlands, England
[3] E Kent Hosp NHS Trust, Kent & Canterbury Hosp, Dept Nucl Med, Canterbury, Kent, England
[4] Univ Hosp N Staffordshire, Directorate Med Phys & Clin Technol, Stoke On Trent, Staffs, England
[5] City Hosp, Dept Phys & Nucl Med, Birmingham, W Midlands, England
[6] Guys & St Thomas Hosp, Dept Med Phys, London SE1 9RT, England
关键词
Radiation dose; Radiation protection; Iodine radioisotopes; Thyroid gland; Hyperthyroidism therapy;
D O I
10.1007/s00259-008-0892-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective The aim of this study was to measure the internal dose received by family members from ingestion of radioactive contamination after outpatient therapy. Materials and methods Advice was given to minimise transfer of radioiodine. Home visits were made approximately 2, 7 and 21 days after treatment to measure radioactivity in the thyroids of family members. A decay correction was applied to radioactivity detected assuming ingestion had occurred at the earlier contact time, either the day of treatment or the previous home visit. An effective half-life of 6 or 7 days was used depending on age. Thyroid activity was summed if activity was found at more than one visit in excess of the amount attributable to radioactive decay. Effective dose (ED) was calculated using ICRP72. Results and discussion Fifty-three adults and 92 children, median age 12 (range 4-17) years participated. Median administered activity was 576 (range 329-690) MBq I-131. Thyroid activity ranged from 0 to 5.4 kBq in the adults with activity detected in 17. Maximum adult ED was 0.4 mSv. Thyroid activity ranged from 0 to 11.8 kBq in the children with activity detected in 26. The two highest values of 5.0 and 11.8 kBq occurred in children aged 5 and 14 years from different families. Eighty-five children had no activity or < 1 kBq detected. ED was < 0.2 mSv in 86 out of 92 children (93%). Previous published data showed 93% of children received an ED <= 0.8 mSv from external irradiation. Conclusion With advice, families of outpatients receiving radioiodine should be able to comply with statutory dose limits and constraints.
引用
收藏
页码:2097 / 2104
页数:8
相关论文
共 50 条
  • [1] Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism
    S. F. Barrington
    P. Anderson
    A. G. Kettle
    R. Gadd
    W. H. Thomson
    S. Batchelor
    P. J. Mountford
    L. K. Harding
    M. J. O’Doherty
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 2097 - 2104
  • [2] Potential third-party radiation exposure from outpatients treated with 131I for hyperthyroidism
    Matheoud, R
    Reschini, E
    Canzi, C
    Voltini, F
    Gerundini, P
    MEDICAL PHYSICS, 2004, 31 (12) : 3194 - 3200
  • [3] Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I
    Pant, GS
    Sharma, SK
    Bal, CS
    Kumar, R
    Rath, GK
    RADIATION PROTECTION DOSIMETRY, 2006, 118 (01) : 22 - 27
  • [4] Measurement of cumulative radiation exposure to children and adolescents in contact with outpatients treated with low dose radioactive iodine (131I)
    Khaled Salman
    Shereen Wagieh
    Aquib Bakhsh
    Tarek Al-Monshy
    Omnia Talaat
    Musaed Al-Malki
    Manal Al-Ezzi
    Ashraf Fouda
    Gihad Hamid
    Journal of the Egyptian National Cancer Institute, 32
  • [5] Measurement of cumulative radiation exposure to children and adolescents in contact with outpatients treated with low dose radioactive iodine (131I)
    Salman, Khaled
    Wagieh, Shereen
    Bakhsh, Aquib
    Al-Monshy, Tarek
    Talaat, Omnia
    Al-Malki, Musaed
    Al-Ezzi, Manal
    Fouda, Ashraf
    Hamid, Gihad
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2020, 32 (01)
  • [6] Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism
    Sally F. Barrington
    Michael J. O’Doherty
    Andrew G. Kettle
    William H. Thomson
    Peter J. Mountford
    David N. Burrell
    Robert J. Farrell
    Stanley Batchelor
    Paul Seed
    L. Keith Harding
    European Journal of Nuclear Medicine, 1999, 26 : 686 - 692
  • [7] Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism
    Barrington, SF
    O'Doherty, MJ
    Kettle, AG
    Thomson, WH
    Mountford, PJ
    Burrell, DN
    Farrell, RJ
    Batchelor, S
    Seed, P
    Harding, LK
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (07) : 686 - 692
  • [8] Therapy with 131I for the resolution of hyperthyroidism in serious illnesses :: Dose selection
    Lopes, Maria Honorina C.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (07) : 1031 - 1033
  • [9] The effect of second dose 131I in patients with hyperthyroidism, being treated by 185MBq low fixed dose regimen
    Bochev, P. H.
    Hristozov, K.
    Klisarova, A.
    Chaushev, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S334 - S334
  • [10] High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease
    Alexander, EK
    Larsen, PR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03): : 1073 - 1077